NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0027236921521653 | 0.42197431 |
NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.0027236921521653 | 0.38867934 |
NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0027236921521653 | 0.37123253 |
NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.0027236921521653 | 0.41874412 |
NSC 757981 | Null | 0.0027236921521653 | 0.41657907 |
NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.00336064452966826 | 0.29220685 |
NSC 244404 | Null | 0.00336064452966826 | 0.48740074 |
NSC 637411 | Null | 0.00336064452966826 | 0.096840657 |
NSC 66301 | Null | 0.00336064452966826 | 0.33130317 |
NSC 666126 | Null | 0.00336064452966826 | 0.25107201 |